Lauren J MacKenzie
Overview
Explore the profile of Lauren J MacKenzie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Villacis-Alvarez E, Sobie C, Maier K, Lavallee M, Daniels C, Pashe H, et al.
Trop Med Infect Dis
. 2024 Dec;
9(12).
PMID: 39728814
Marginalized groups in Manitoba, Canada, especially females and people who inject drugs, are overrepresented in new HIV diagnoses and disproportionately affected by HIV and structural disadvantages. Informed by syndemic theory,...
2.
Leeies M, Collister D, Ho J, Trachtenberg A, Gruber J, Weiss M, et al.
Am J Transplant
. 2023 Mar;
23(6):707-726.
PMID: 36997028
Sexual orientation and gender identity (SOGI)-diverse populations experience discrimination in organ and tissue donation and transplantation (OTDT) systems globally. We assembled a multidisciplinary group of clinical experts as well as...
3.
Lofgren S, Nicol M, Bangdiwala A, Pastick K, Okafor E, Skipper C, et al.
Open Forum Infect Dis
. 2020 Nov;
7(11):ofaa500.
PMID: 33204764
Background: Use of hydroxychloroquine in hospitalized patients with coronavirus disease 2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. Here, we report safety data from 3 outpatient randomized...
4.
Rajasingham R, Bangdiwala A, Nicol M, Skipper C, Pastick K, Axelrod M, et al.
Clin Infect Dis
. 2020 Oct;
72(11):e835-e843.
PMID: 33068425
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no known effective prophylaxis. We investigated whether hydroxychloroquine...
5.
Rajasingham R, Bangdiwala A, Nicol M, Skipper C, Pastick K, Axelrod M, et al.
medRxiv
. 2020 Sep;
PMID: 32995820
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging virus causing the ongoing Covid-19 pandemic with no known effective prophylaxis. We investigated whether hydroxychloroquine could prevent SARS...
6.
Lofgren S, Nicol M, Bangdiwala A, Pastick K, Okafor E, Skipper C, et al.
medRxiv
. 2020 Aug;
PMID: 32743591
Introduction: Use of hydroxychloroquine in hospitalized patients with COVID-19, especially in combination with azithromycin, has raised safety concerns. Here, we report safety data from three outpatient randomized clinical trials. Methods:...
7.
Skipper C, Pastick K, Engen N, Bangdiwala A, Abassi M, Lofgren S, et al.
Ann Intern Med
. 2020 Jul;
173(8):623-631.
PMID: 32673060
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19). Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients. Design: Randomized, double-blind, placebo-controlled trial conducted...
8.
Lee T, MacKenzie L, McDonald E, Tong S
Int J Infect Dis
. 2020 Jul;
98:216-217.
PMID: 32623080
No abstract available.
9.
Boulware D, Pullen M, Bangdiwala A, Pastick K, Lofgren S, Okafor E, et al.
N Engl J Med
. 2020 Jun;
383(6):517-525.
PMID: 32492293
Background: Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether...
10.
Lother S, Abassi M, Agostinis A, Bangdiwala A, Cheng M, Drobot G, et al.
Can J Anaesth
. 2020 May;
67(9):1201-1211.
PMID: 32383125
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there is a lack of evidence-based therapies to prevent COVID-19...